Literature DB >> 22418889

Exercise and the liver: implications for therapy in fatty liver disorders.

Nathan A Johnson1, Shelley E Keating, Jacob George.   

Abstract

The increasing recognition that fatty liver plays a direct role in the pathogenesis of cardiovascular and metabolic disease has resulted in significant research enquiry into the efficacy of lifestyle therapy in modulating liver fat. Recently, this has extended to the specific investigation of a possible independent benefit of physical activity/exercise in nonalcoholic fatty liver disease (NAFLD). In this article we review the effect of acute and regular exercise (training) on metabolism, including liver glucose and lipid metabolism, and the available human trials that have compared the benefit of regular exercise versus a nonexercise control on liver fat. The limited human research suggests that exercise can reduce liver fat and that this benefit may be mediated, in part, by a reduction in hepatic lipogenesis. The relative importance of extrahepatic adaptations and acute versus regular exercise in explaining this benefit are discussed. From a clinical perspective, the revelation of a benefit of exercise per se offers a novel approach for liver fat reduction, and highlights the importance of incorporating fitness assessment and prescription in the management of patients with fatty liver disorders. Implementation of exercise therapy in a clinical setting is arguably the biggest challenge because evidence shows that mere provision of information about the benefits of exercise and/or exercise prescription to the patient does not translate to positive outcomes. Rather, the focus should be on implementing strategies to promote behavior change including regular contact and assessment with a health care professional, self-monitoring, and personalization of goals that focus on changing physical activity behavior. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22418889     DOI: 10.1055/s-0032-1306427

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  20 in total

1.  NAFLD: The role of exercise in treating NAFLD.

Authors:  Elena Reynoso; Joel E Lavine
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

Review 2.  Physical activity for the prevention and treatment of metabolic disorders.

Authors:  Luca Montesi; Simona Moscatiello; Marcella Malavolti; Rebecca Marzocchi; Giulio Marchesini
Journal:  Intern Emerg Med       Date:  2013-05-09       Impact factor: 3.397

3.  Short-term aerobic exercise training improves gut peptide regulation in nonalcoholic fatty liver disease.

Authors:  Emily L Kullman; Karen R Kelly; Jacob M Haus; Ciaran E Fealy; Amanda R Scelsi; Mangesh R Pagadala; Chris A Flask; Arthur J McCullough; John P Kirwan
Journal:  J Appl Physiol (1985)       Date:  2016-03-31

4.  Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012.

Authors:  Kenichi Nishioji; Yoshio Sumida; Mai Kamaguchi; Naomi Mochizuki; Masao Kobayashi; Takeshi Nishimura; Kanji Yamaguchi; Yoshito Itoh
Journal:  J Gastroenterol       Date:  2014-03-12       Impact factor: 7.527

5.  Physical activity support or weight loss counseling for nonalcoholic fatty liver disease?

Authors:  Luca Montesi; Chiara Caselli; Elena Centis; Chiara Nuccitelli; Simona Moscatiello; Alessandro Suppini; Giulio Marchesini
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Antihyperlipidemic and antitumor effects of chickpea albumin hydrolysate.

Authors:  Zhaohui Xue; Jie Gao; Zhijun Zhang; Wancong Yu; Hua Wang; Xiaohong Kou
Journal:  Plant Foods Hum Nutr       Date:  2012-12       Impact factor: 3.921

Review 7.  Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.

Authors:  Pegah Golabi; Cameron T Locklear; Patrick Austin; Sophie Afdhal; Melinda Byrns; Lynn Gerber; Zobair M Younossi
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

8.  Pathogenesis and Prevention of Hepatic Steatosis.

Authors:  Fatiha Nassir; R Scott Rector; Ghassan M Hammoud; Jamal A Ibdah
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-03

9.  Physical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.

Authors:  Maureen Whitsett; Lisa B VanWagner
Journal:  World J Hepatol       Date:  2015-08-08

10.  Polycystic ovary syndrome and nonalcoholic fatty liver in obese adolescents: association with metabolic risk profile.

Authors:  Sara F Michaliszyn; Sojung Lee; Hala Tfayli; Silva Arslanian
Journal:  Fertil Steril       Date:  2013-09-11       Impact factor: 7.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.